{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T06:09:04Z","timestamp":1789366144642,"version":"build-2803163510"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1097\/inf.0000000000001203","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T11:30:42Z","timestamp":1463052642000},"page":"879-885","source":"Crossref","is-referenced-by-count":19,"title":["High Rates of Drug Resistance Among Newly Diagnosed HIV-infected Children in the National Prevention of Mother-to-child Transmission Program in Togo"],"prefix":"10.1097","volume":"35","author":[{"given":"Mounerou","family":"Salou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Butel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abla A.","family":"Konou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier K.","family":"Ekouevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sika","family":"Dossim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koko","family":"Lawson-Evi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawo T.","family":"Nyasenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assetina","family":"Singo-Tokofa\u00ef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senyedji","family":"d\u2019Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00efssa","family":"Tchama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Delaporte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Prince-David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoumou Y.","family":"Dagnra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R5-11-20210202","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/jit110","article-title":"Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomes.","volume":"207","author":"Paredes","year":"2013","journal-title":"J Infect Dis"},{"key":"R6-11-20210202","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/1570162X11311020005","article-title":"HIV drug resistance in mothers and infants following use of antiretrovirals to prevent mother-to-child transmission.","volume":"11","author":"Ton","year":"2013","journal-title":"Curr HIV Res"},{"key":"R7-11-20210202","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1097\/INF.0b013e31827f44ee","article-title":"Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants.","volume":"32","author":"Fogel","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R8-11-20210202","doi-asserted-by":"crossref","first-page":"e1000430","DOI":"10.1371\/journal.pmed.1000430","article-title":"HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis.","volume":"8","author":"Zeh","year":"2011","journal-title":"PLoS Med"},{"key":"R9-11-20210202","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/ije\/dym104","article-title":"Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis.","volume":"36","author":"Arriv\u00e9","year":"2007","journal-title":"Int J Epidemiol"},{"key":"R10-11-20210202","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/COH.0b013e328363d280","article-title":"Prevention of mother-to-child HIV transmission: can we meet the goal of global elimination of new pediatric infections?","volume":"8","author":"Mofenson","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"R11-11-20210202","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1473-3099(10)70288-7","article-title":"Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.","volume":"11","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"R12-11-20210202","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1097\/QAD.0000000000000492","article-title":"Adherence to extended postpartum antiretrovirals is associated with decreased breast milk HIV-1 transmission.","volume":"28","author":"Davis","year":"2014","journal-title":"AIDS"},{"key":"R13-11-20210202","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1089\/aid.2014.0158","article-title":"HIV-1 drug resistance mutations among infants born to HIV-positive mothers in Busia, Kenya.","volume":"30","author":"Lel","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R15-11-20210202","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/cid\/cis003","article-title":"World Health Organization generic protocol to assess drug-resistant HIV among children<18 months of age and newly diagnosed with HIV in resource-limited countries.","volume":"54","author":"Bertagnolio","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R16-11-20210202","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1128\/JCM.02255-08","article-title":"Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing.","volume":"47","author":"Monleau","year":"2009","journal-title":"J Clin Microbiol"},{"key":"R17-11-20210202","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/sysbio\/syq010","article-title":"New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0.","volume":"59","author":"Guindon","year":"2010","journal-title":"Syst Biol"},{"key":"R18-11-20210202","doi-asserted-by":"crossref","first-page":"e111042","DOI":"10.1371\/journal.pone.0111042","article-title":"Minority drug-resistant HIV-1 variants in treatment na\u00efve East-African and Caucasian patients detected by allele-specific real-time PCR.","volume":"9","author":"Ekici","year":"2014","journal-title":"PLoS One"},{"key":"R19-11-20210202","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jviromet.2014.07.010","article-title":"Concordance between allele-specific PCR and ultra-deep pyrosequencing for the detection of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations.","volume":"207","author":"Hunt","year":"2014","journal-title":"J Virol Methods"},{"key":"R20-11-20210202","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/QAD.0000000000000267","article-title":"Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure.","volume":"28","author":"Mohamed","year":"2014","journal-title":"AIDS"},{"key":"R21-11-20210202","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1097\/QAD.0000000000000397","article-title":"Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients.","volume":"28","author":"Metzner","year":"2014","journal-title":"AIDS"},{"key":"R22-11-20210202","doi-asserted-by":"crossref","first-page":"e86771","DOI":"10.1371\/journal.pone.0086771","article-title":"Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failure.","volume":"9","author":"Vandenhende","year":"2014","journal-title":"PLoS One"},{"key":"R23-11-20210202","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/QAD.0000000000000261","article-title":"Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis.","volume":"28","author":"Kuhn","year":"2014","journal-title":"AIDS"},{"key":"R24-11-20210202","doi-asserted-by":"crossref","first-page":"18526","DOI":"10.7448\/IAS.17.1.18526","article-title":"The case for addressing primary resistance mutations to non-nucleoside reverse transcriptase inhibitors to treat children born from mothers living with HIV in sub-Saharan Africa.","volume":"17","author":"K\u00e9b\u00e9","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"R25-11-20210202","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/jac\/dku087","article-title":"HIV-1 drug mutations in children from northern Tanzania.","volume":"69","author":"Shao","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"R26-11-20210202","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1128\/AAC.01117-08","article-title":"Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy.","volume":"53","author":"Mirochnick","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R27-11-20210202","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/QAI.0b013e31829c48ad","article-title":"Hair and plasma data show that lopinavir, ritonavir, and efavirenz all transfer from mother to infant in utero, but only efavirenz transfers via breastfeeding.","volume":"63","author":"Gandhi","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R28-11-20210202","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/jac\/dkv080","article-title":"Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important? A systematic review and meta-analysis of pharmacokinetic studies.","volume":"70","author":"Waitt","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R29-11-20210202","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.arcped.2014.07.006","article-title":"[Accessibility of early infant diagnosis of HIV infection in Lome (Togo)].","volume":"21","author":"Bouraima","year":"2014","journal-title":"Arch Pediatr"},{"key":"R30-11-20210202","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jac\/dkn441","article-title":"Persistence of nevirapine in breast milk and plasma of mothers and their children after single-dose administration.","volume":"63","author":"Kunz","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R32-11-20210202","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.meegid.2009.04.002","article-title":"Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.","volume":"9","author":"Dagnra","year":"2009","journal-title":"Infect Genet Evol"},{"key":"R33-11-20210202","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/cid\/cit627","article-title":"Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-Saharan Africa and southeast Asia.","volume":"58","author":"Aghokeng","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R34-11-20210202","doi-asserted-by":"crossref","first-page":"e68213","DOI":"10.1371\/journal.pone.0068213","article-title":"Evolution of primary HIV drug resistance in a subtype C dominated epidemic in Mozambique.","volume":"8","author":"Bila","year":"2013","journal-title":"PLoS One"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000001203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T01:51:17Z","timestamp":1655862677000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201608000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001203","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}